1-7 of 7
Monica Bellei, MSc, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study

Emilio Iannitto, MD, Monica Bellei, MSc, PhD, Andrés J M Ferreri, MD, Luigi Marcheselli, MS, Marina Cesaretti, MD, Corinne Haioun, Salvatrice Mancuso, Krimo Bouabdallah, MD, Remy Gressin, MD, Claudio Tripodo, MD, Alexandra traverse-Glehen, MD PhD, Lucile Baseggio, MD, Simonetta Zupo, Caterina Stelitano, Barbara Castagnari, MD, Caterina Patti, MD, Francesco Merli, Anna Marina Liberati, MD, Michele Merli, Guido Gini, Maria Giuseppina Cabras, Jehan Dupuis, MD, Francesca Re, Emanuele Zucca, MD, Massimo Federico, MD, Catherine Thieblemont, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4062.
https://doi.org/10.1182/blood.V130.Suppl_1.4062.4062
Published: 2017
Journal Articles

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project

Andrei Shustov, MD, Maria Elena Cabrera, Monica Bellei, MSc, PhD, Young Hyeh Ko, MD, Martina Manni, PhD, Steven M. Horwitz, MD, Carmino Antonio De Souza, MD PhD, John A. Radford, MD, Sabela Bobillo Varela, Maria Virginia Prates, MD, Andrés J M Ferreri, MD, Carlos Chiattone, MD, Michele Spina, MD, Julie M. Vose, MDMBA, Annalisa Chiappella, MD, Daniele Laszlo, MD, Dario Marino, MDPhD, Caterina Stelitano, Massimo Federico, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4071.
https://doi.org/10.1182/blood.V130.Suppl_1.4071.4071
Published: 2017
Journal Articles

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Positive (ALCL, ALK+): Data from 119 Patients Prospectively Registered in the International T-Cell Project

Andrei Shustov, MD, Monica Bellei, MSc, PhD, Stefano A. Pileri, Silvia Montoto, Martina Manni, PhD, Steven M. Horwitz, MD, Maria Elena Cabrera, Carlos Chiattone, MD, Arnon Nagler, MD, Sonia González de Villambrosia, Maria Angeles Perez Saenz, MD, Francesco Merli, Andrés J M Ferreri, MD, Maria Virginia Prates, MD, Kenneth R. Carson, MD PhD, Alessandro Re, MD, Luigi Rigacci, Luca Nassi, Vittorio Ruggero Zilioli, Massimo Federico, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4072.
https://doi.org/10.1182/blood.V130.Suppl_1.4072.4072
Published: 2017
Journal Articles

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Luc-Matthieu Fornecker, Julien Lazarovici, MD, Igor Aurer, PhD, Rene-Olivier Casasnovas, MD, Anne-Claire Gac, Christophe Bonnet, MD PhD, Krimo Bouabdallah, MD, Aurore Perrot, MD, Lena Specht, Mohamed Touati, Jean Claude Eisenmann, Cecile Borel, MD, Aspasia Stamatoullas, MD, Emmanuelle Nicolas-Virelizier, MD, Laurent Pascal, Pieternella Lugtenburg, Monica Bellei, MSc, PhD, Alexandra traverse-Glehen, MD PhD, Christiane Copie, MDPhD, Martin Hutchings, MD PhD, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 736.
https://doi.org/10.1182/blood.V130.Suppl_1.736.736
Published: 2017
Journal Articles

Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study

Miriam López-Parra, MD, Monica Bellei, MSc, PhD, Alessandro Rambaldi, MD Prof, Silvana Novelli, Carlos Panizo, MD PhD, Maurizio Martelli, Ivan Dlouhy, Mariana Bastos, MD, Antonio Gutierrez, MD PhD, Juan Manuel Sancho, MD PhD, María José Ramírez Sánchez, José M Moraleda, MD, Estrella Carrillo-Cruz, MD, Ana Isabel Jiménez Ubieto, Isidro Jarque, Umberto Vitolo, MD, Natalia de las Heras, Reyes Arranz, Javier Lopez Jimenez, Carlos Montalban, MD PhD, Maria Pascual, Paolo Corradini, MD, Sabela Bobillo, MD, Estefania García-Torres, Michele Spina, Giuseppe Rossi, MD, Martina Manni, PhD, Dolores Caballero, MD PhD, Massimo Federico, MD, Alejandro Martín, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2008.
https://doi.org/10.1182/blood.V130.Suppl_1.2008.2008
Published: 2017
Journal Articles

Outcome of Patients with Gamma Delta T Cell Lymphomas: Analysis of 1429 Cases Registered in the Prospective T-Cell Project

Francine M Foss, MD, Steven M. Horwitz, MD, Monica Bellei, MSc, PhD, Martina Manni, PhD, Vittoria Tarantino, Andrei R. Shustov, MD, Ivan Dlouhy, Maria Elena Cabrera, Won Seog Kim, MD, Ph. D., Felicitas - Hitz, MD, Raul Gabus, MD, Antonio Gutierrez, MD PhD, Sabela Bobillo Varela, Umberto Vitolo, Francesco Merli, Veronika Ballova, MD, Andrew Davies, PhD, Maria Giuseppina Cabras, Francesco Di Raimondo, MD, Massimo Federico
Journal: Blood
Blood (2017) 130 (Supplement 1): 1512.
https://doi.org/10.1182/blood.V130.Suppl_1.1512.1512
Published: 2017
Journal Articles

Chlorambucil Plus Rituximab Produces Better Event-Free Survival in Comparison with Chlorambucil Alone in the Treatment of MALT Lymphoma: 5-Year Analysis of the 2-Arms Part of the IELSG-19 Randomized Study

Emanuele Zucca, MD, Annarita Conconi, MD, Giovanni Martinelli, MD, Maurizio Martelli, MD, Catherine Thieblemont, MD, Peter W Johnson, MD, FRCP, Armando Lopez-Guillermo, MD, Reda Bouabdallah, MD, Alessandra Tucci, MD, Umberto Vitolo, MD, Bertrand Coiffier, MD, PhD, Liliana Devizzi, MD, Fabrice Jardin, MD, PhD, Catherine Sebban, MD, Graziella Pinotti, MD, Franck Morschhauser, MD, PhD, Ruth Pettengell, FRACP, PhD, Andre Bosly, MD, Emili Montserrat, MD, Monica Bellei, MSc, PhD, Stefano A. Pileri, MD, Christiane Copie-Bergman, MD, PhD, Elias Campo, MD, Andrew Jack, PhD, MB, Luca Mazzucchelli, MD, Franco Cavalli, MD, FRCP
Journal: Blood
Blood (2010) 116 (21): 432.
https://doi.org/10.1182/blood.V116.21.432.432
Published: 2010